We are live on ! Find out more
CYAD

Celyad Oncology SA American Depositary Shares
CYAD

Delisted

CYAD was delisted on the 18th of May, 2023.

Back to rankings

13 hedge funds and large institutions have $37.6M invested in Celyad Oncology SA American Depositary Shares in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+13
Holders Change %
–
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RIM
RS Investment Management
California
+$12.8M
2
UBS Group
UBS Group
Switzerland
+$5.65M
3
Millennium Management
Millennium Management
New York
+$4.41M
4
CAM
Cormorant Asset Management
Massachusetts
+$4.03M
5
PA
Perceptive Advisors
New York
+$4.03M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RIM
1
RS Investment Management
California
$12.4M +$12.8M +238,330 New
UBS Group
2
UBS Group
Switzerland
$5.47M +$5.65M +105,098 New
Millennium Management
3
Millennium Management
New York
$4.26M +$4.41M +81,942 New
CAM
4
Cormorant Asset Management
Massachusetts
$3.9M +$4.03M +75,000 New
PA
5
Perceptive Advisors
New York
$3.9M +$4.03M +75,000 New
HM
6
HealthCor Management
New York
$3.38M +$3.5M +65,000 New
DCM
7
DAFNA Capital Management
California
$1.56M +$1.61M +30,000 New
FCM
8
Farallon Capital Management
California
$1.56M +$1.61M +30,000 New
UOC
9
UBS O'Connor
Illinois
$780K +$807K +15,000 New
FMA
10
FNY Managed Accounts
New York
$286K +$296K +5,500 New
TRCT
11
Tower Research Capital (TRC)
New York
$41K +$42.1K +783 New
Morgan Stanley
12
Morgan Stanley
New York
$26K +$26.9K +500 New
AH
13
Achievement Holdings
Illinois
$1.09K +$1.13M +21,000 New

CYAD Hedge Fund Activity: Q2 2015 in Review

13 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Celyad Oncology SA American Depositary Shares (CYAD) for Q2 2015, worth a combined $37.6M.

Buyers outnumbered sellers: 13 funds opened new CYAD positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RS Investment Management, opening a new position worth an estimated $12.8M.

  • 13 institutional investors held Celyad Oncology SA American Depositary Shares (CYAD) as of Q2 2015, up from 0 in Q1 2015.
  • Funds reported $37.6M of Celyad Oncology SA American Depositary Shares stock for Q2 2015.
  • 13 funds opened new Celyad Oncology SA American Depositary Shares positions in Q2 2015 and 0 closed out, a net change of +13 holders.
  • The largest Celyad Oncology SA American Depositary Shares buyer in Q2 2015 was RS Investment Management, an estimated $12.8M added.

Based on aggregated 13F filings for Q2 2015.